An appraisal of smoking cessation aidsMundey, KavitaCurrent Opinion in Pulmonary Medicine: March 2009 - Volume 15 - Issue 2 - p 105–112 doi: 10.1097/MCP.0b013e328321862e Obstructive, occupational and environmental diseases: Edited by Basil Varkey Buy Abstract Author InformationAuthors Article MetricsMetrics Purpose of review Smoking cessation is the single most efficacious intervention to reduce and prevent smoking-associated morbidity and mortality. This review presents an updated summary of current treatment options. Resources available for management of smoking cessation efforts and variables that may guide treatment of subgroups of patients have also been highlighted. Recent findings The US Department of Health and Human Services released updated guidelines for treatment of smoking cessation in 2008. Recent meta-analyses have reviewed the newly Food and Drug Administration approved drug, varenicline, as well as some new nonpharmacological approaches to treating tobacco dependence. Summary Several pharmacologic and nonpharmacologic aids have proven efficacy in smoking cessation management. The best results are obtained by combining modalities. Tailoring therapy improves success rate. Division of Pulmonary, Critical Care and Sleep Medicine, Medical College of Wisconsin, Wisconsin, USA Correspondence to Kavita Mundey, MD, Division of Pulmonary, Critical Care and Sleep Medicine, Medical College of Wisconsin, 9200 W. Wisconsin Aveue, Milwaukee, WI 53226, USA Tel: +1 414 955 7043; e-mail: email@example.com © 2009 Lippincott Williams & Wilkins, Inc.